Navigation Links
Pitt-led research provides insight into development of congenital circulatory defects
Date:7/8/2008

PITTSBURGHUniversity of Pittsburgh-led researchers could provide new insight into how two common congenital circulatory problemsaortic arch deformity and arteriovenous malformations (AVMs)develop in humans, as reported in the June 15 edition of Developmental Biology.

Led by Beth Roman, an assistant professor of biological sciences in Pitt's School of Arts and Sciences, the team created the first complete published description of how aortic arch vessels form and, in a separate finding also described in the paper, determined that AVMswherein an artery fuses with a vein and diverts blood flowcan form as a result of combined genetic and physiological factors and not solely because of genetics.

The team created the aortic arch vessel development model from zebrafish embryos, which develop similarly to humans but more rapidly. In humans, the aortic arch vessels contribute to several of the body's major arteries and often develop improperly, resulting in a wide range of vascular defects. The model could allow for a better understanding of the genetic program that governs aortic arch development, and therefore help in predicting abnormalities and determining when and how to intervene.

From the model, the team discovered that the gene unc45a plays a critical and previously unknown role in the formation of the aortic arch vesselsand that mutations in that gene can result in AVMs. In zebrafish harboring the mutation, two aortic arch vessels failed to connect properly to the body's major artery, the dorsal aorta. Instead, dead-end vessels formed then swelled with blood until they touched and fused with a nearby vein.

AVMs typically form embryonically, but the particular AVMs Roman's team observed did not form in the absence of blood flow, indicating that they were not genetically hardwired, she said. Additionally, AVM formation was inconsistent in terms of location on the aortic arch vessel, Roman said. The mutants randomly developed AVMs on the side of the dead-end vesselleft, right, or boththat happened to receive blood flow first.

While AVMs in humans are generally thought to form in utero, they typically are discovered only when they cause a serious health problem later in life. AVMs can form in various organs, including the brain, lungs, spinal cord, and liver. By diverting blood, the misconnections rob parts of the body of nutrients and oxygen. The fragile fusions are prone to rupturing and hemorrhaging; a ruptured AVM in the brain can cause a stroke.

"We discover AVMs in humans when something goes wrong and we can never go back and trace the shunt's development," Roman said. "Only when we fully understand the mechanisms leading to these malformations will we be able to develop better diagnostic tests and preventative treatments to pinpoint the best time to intervene."


'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert

Related medicine news :

1. Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery
2. Orange County research program aims to improve severe trauma survival rates
3. Autism Research Institute Launches Mobile Website
4. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
5. Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
6. New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin
7. Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
8. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
9. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
10. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
11. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
Breaking Medicine Technology: